119 related articles for article (PubMed ID: 2512447)
1. Immunohistochemical demonstration of GM2-ganglioside in the central nervous system of a 19-week-old fetus of Tay-Sachs disease.
Taniike M; Inui K; Hirabayashi Y; Tsukamoto H; Nishimoto J; Midorikawa M; Okada S; Yabuuchi H
J Inherit Metab Dis; 1989; 12 Suppl 2():372-4. PubMed ID: 2512447
[No Abstract] [Full Text] [Related]
2. Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?
Rosengren B; Månsson JE; Svennerholm L
J Neurochem; 1987 Sep; 49(3):834-40. PubMed ID: 3612128
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of lysoganglioside lyso-GM2 (II3-Neu5Ac-gangliotriaosylsphingosine) in GM2 gangliosidosis brain.
Neuenhofer S; Conzelmann E; Schwarzmann G; Egge H; Sandhoff K
Biol Chem Hoppe Seyler; 1986 Mar; 367(3):241-4. PubMed ID: 3707714
[TBL] [Abstract][Full Text] [Related]
4. Characterization of some minor gangliosides in Tay-Sachs brains.
Yu RK; Itoh T; Yohe HC; Macala LJ
Brain Res; 1983 Sep; 275(1):47-52. PubMed ID: 6414648
[No Abstract] [Full Text] [Related]
5. Prenatal diagnosis of GM2-gangliosidosis. Immunofluorescence analysis of ganglioside GM2 in cultured amniocytes by confocal laser scanning microscopy.
Sakuraba H; Itoh K; Kotani M; Tai T; Yamada H; Kurosawa K; Kuroki Y; Suzuki H; Utsunomiya T; Inoue H
Brain Dev; 1993; 15(4):278-82. PubMed ID: 8250149
[TBL] [Abstract][Full Text] [Related]
6. GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease.
Demir SA; Timur ZK; Ateş N; Martínez LA; Seyrantepe V
J Neuroinflammation; 2020 Sep; 17(1):277. PubMed ID: 32951593
[TBL] [Abstract][Full Text] [Related]
7. GM2 ganglioside in fetal Tay-Sachs disease brain cultures: a model system for the disease.
Hoffman LM; Amsterdam D; Schneck L
Brain Res; 1976 Jul; 111(1):109-17. PubMed ID: 953690
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunosorbent assay for the ganglioside GM2-activator protein. Screening of normal human tissues and body fluids, of tissues of GM2 gangliosidosis, and for its subcellular localization.
Banerjee A; Burg J; Conzelmann E; Carroll M; Sandhoff K
Hoppe Seylers Z Physiol Chem; 1984 Mar; 365(3):347-56. PubMed ID: 6724528
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of ganglioside Gm2 in cerebrospinal fluid of a patient with the variant AB of infantile Gm2 gangliosidosis.
Pullarkat RK; Reha H; Beratis NG
Pediatrics; 1981 Jul; 68(1):106-8. PubMed ID: 7243492
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
Poulos A; Holding J; Carey WF
Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
[TBL] [Abstract][Full Text] [Related]
11. Sialidase-mediated depletion of GM2 ganglioside in Tay-Sachs neuroglia cells.
Igdoura SA; Mertineit C; Trasler JM; Gravel RA
Hum Mol Genet; 1999 Jun; 8(6):1111-6. PubMed ID: 10332044
[TBL] [Abstract][Full Text] [Related]
12. Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease.
Chen Y; Allegood J; Liu Y; Wang E; Cachón-Gonzalez B; Cox TM; Merrill AH; Sullards MC
Anal Chem; 2008 Apr; 80(8):2780-8. PubMed ID: 18314967
[TBL] [Abstract][Full Text] [Related]
13. Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase A.
Hoffman LM; Brooks SE; Amsterdam D; Oropello J; Schneck L
J Neurosci Res; 1980; 5(5):413-7. PubMed ID: 7441795
[TBL] [Abstract][Full Text] [Related]
14. Gangliosides in SV-40-transformed cells derived from Tay-Sachs disease fetal brain.
Hoffman LM; Brooks SE; Stein MR; Adachi M; Schneck L
Metab Brain Dis; 1989 Jun; 4(2):87-93. PubMed ID: 2547146
[TBL] [Abstract][Full Text] [Related]
15. [Identification of GM2-gangliosidosis using an in vitro loading test].
Akhunov VS; Krasnopol'skaia KD
Vopr Med Khim; 1987; 33(4):115-9. PubMed ID: 3116767
[TBL] [Abstract][Full Text] [Related]
16. Evidence for direct binding of intracellularly distributed ganglioside GM2 to isolated vimentin intermediate filaments in normal and Tay-Sachs disease human fibroblasts.
Kotani M; Hosoya H; Kubo H; Itoh K; Sakuraba H; Kusubata M; Inagaki M; Yazaki S; Suzuki Y; Tai T
Cell Struct Funct; 1994 Apr; 19(2):81-7. PubMed ID: 7923401
[TBL] [Abstract][Full Text] [Related]
17. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.
Sango K; Yamanaka S; Hoffmann A; Okuda Y; Grinberg A; Westphal H; McDonald MP; Crawley JN; Sandhoff K; Suzuki K; Proia RL
Nat Genet; 1995 Oct; 11(2):170-6. PubMed ID: 7550345
[TBL] [Abstract][Full Text] [Related]
18. Adult-onset GM2 gangliosidosis. Seizures, dementia, and normal pressure hydrocephalus associated with glycolipid storage in the brain and arachnoid granulation.
O'Neill B; Butler AB; Young E; Falk PM; Bass NH
Neurology; 1978 Nov; 28(11):1117-23. PubMed ID: 568730
[No Abstract] [Full Text] [Related]
19. Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers.
Hirabayashi Y; Kasakura H; Matsumoto M; Higashi H; Kato S; Kasai N; Naiki M
Jpn J Cancer Res; 1987 Mar; 78(3):251-60. PubMed ID: 3106281
[TBL] [Abstract][Full Text] [Related]
20. [Biosynthesis and biodegradation of GM2 ganglioside].
Hirabayashi Y; Kasakura H; Matsumoto M
Tanpakushitsu Kakusan Koso; 1984 Sep; 29(9):708-22. PubMed ID: 6240072
[No Abstract] [Full Text] [Related]
[Next] [New Search]
